Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy

Guido Cavaletti; G. Bogliun; L. Marzorati; A. Zincone; M. Piatti; N. Colombo; D. Franchi; M. T. La Presa; A. Lissoni; A. Buda; F. Fei; S. Cundari; C. Zanna

doi:10.1093/annonc/mdh348

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy

Guido Cavaletti, G. Bogliun, L. Marzorati, A. Zincone, M. Piatti, N. Colombo, D. Franchi, M. T. La Presa, A. Lissoni, A. Buda, F. Fei, S. Cundari, C. Zanna

Istituto Europeo di Oncologia

Research output: Contribution to journal › Article › peer-review

Abstract

Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome of CIPN. Patients and methods: Sixty-two women affected by locally advanced squamous cervical carcinoma treated with TP (paclitaxel 175 mg/m² over a 3 h infusion plus cisplatin 75 mg/m²) or TIP (TP plus ifosphamide 5 mg/m²) were examined and scored according to the Total Neuropathy Score (TNS), before and during chemotherapy. Results: A correlation with the final severity of CIPN was observed with vibration perception and deep tendon reflex evaluation, while pin sensibility, strength, and autonomic symptoms and signs were not informative. A highly significant correlation existed between the decrease in circulating levels of NGF and the severity of CIPN (r=-0.579; P

Original language	English
Pages (from-to)	1439-1442
Number of pages	4
Journal	Annals of Oncology
Volume	15
Issue number	9
DOIs	https://doi.org/10.1093/annonc/mdh348
Publication status	Published - Sep 2004

Keywords

Chemotherapy
Cisplatin
Neuropathy
Paclitaxel

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/annonc/mdh348

Cite this

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. / Cavaletti, Guido; Bogliun, G.; Marzorati, L.; Zincone, A.; Piatti, M.; Colombo, N.; Franchi, D.; La Presa, M. T.; Lissoni, A.; Buda, A.; Fei, F.; Cundari, S.; Zanna, C.

In: Annals of Oncology, Vol. 15, No. 9, 09.2004, p. 1439-1442.

Research output: Contribution to journal › Article › peer-review

@article{2e260e2dcc2c45cc91d621a8d01b752f,

title = "Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy",

abstract = "Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome of CIPN. Patients and methods: Sixty-two women affected by locally advanced squamous cervical carcinoma treated with TP (paclitaxel 175 mg/m2 over a 3 h infusion plus cisplatin 75 mg/m2) or TIP (TP plus ifosphamide 5 mg/m2) were examined and scored according to the Total Neuropathy Score (TNS), before and during chemotherapy. Results: A correlation with the final severity of CIPN was observed with vibration perception and deep tendon reflex evaluation, while pin sensibility, strength, and autonomic symptoms and signs were not informative. A highly significant correlation existed between the decrease in circulating levels of NGF and the severity of CIPN (r=-0.579; P ",

keywords = "Chemotherapy, Cisplatin, Neuropathy, Paclitaxel",

author = "Guido Cavaletti and G. Bogliun and L. Marzorati and A. Zincone and M. Piatti and N. Colombo and D. Franchi and {La Presa}, {M. T.} and A. Lissoni and A. Buda and F. Fei and S. Cundari and C. Zanna",

year = "2004",

month = sep,

doi = "10.1093/annonc/mdh348",

language = "English",

volume = "15",

pages = "1439--1442",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "9",

}

TY - JOUR

T1 - Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy

AU - Cavaletti, Guido

AU - Bogliun, G.

AU - Marzorati, L.

AU - Zincone, A.

AU - Piatti, M.

AU - Colombo, N.

AU - Franchi, D.

AU - La Presa, M. T.

AU - Lissoni, A.

AU - Buda, A.

AU - Fei, F.

AU - Cundari, S.

AU - Zanna, C.

PY - 2004/9

Y1 - 2004/9

N2 - Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome of CIPN. Patients and methods: Sixty-two women affected by locally advanced squamous cervical carcinoma treated with TP (paclitaxel 175 mg/m2 over a 3 h infusion plus cisplatin 75 mg/m2) or TIP (TP plus ifosphamide 5 mg/m2) were examined and scored according to the Total Neuropathy Score (TNS), before and during chemotherapy. Results: A correlation with the final severity of CIPN was observed with vibration perception and deep tendon reflex evaluation, while pin sensibility, strength, and autonomic symptoms and signs were not informative. A highly significant correlation existed between the decrease in circulating levels of NGF and the severity of CIPN (r=-0.579; P

AB - Background: We investigated the possible use of clinical signs of chemotherapy-induced peripheral neurotoxicity (CIPN) or of nerve growth factor (NGF) circulating levels to predict the final outcome of CIPN. Patients and methods: Sixty-two women affected by locally advanced squamous cervical carcinoma treated with TP (paclitaxel 175 mg/m2 over a 3 h infusion plus cisplatin 75 mg/m2) or TIP (TP plus ifosphamide 5 mg/m2) were examined and scored according to the Total Neuropathy Score (TNS), before and during chemotherapy. Results: A correlation with the final severity of CIPN was observed with vibration perception and deep tendon reflex evaluation, while pin sensibility, strength, and autonomic symptoms and signs were not informative. A highly significant correlation existed between the decrease in circulating levels of NGF and the severity of CIPN (r=-0.579; P

KW - Chemotherapy

KW - Cisplatin

KW - Neuropathy

KW - Paclitaxel

UR - http://www.scopus.com/inward/record.url?scp=4644282779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644282779&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdh348

DO - 10.1093/annonc/mdh348

M3 - Article

C2 - 15319252

AN - SCOPUS:4644282779

VL - 15

SP - 1439

EP - 1442

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this